| 1 |
de Andrade IA, Franca LV, Kauffmann CM, Maeda MHK, Koyama LHH, Hamann PRV, Lopes-Luz L, Fogaça MBT, de Camargo BR, Ribeiro BM, Bührer-Sékula S, Nagata T. Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants. J Virol Methods 2023;315:114710. [PMID: 36914098 DOI: 10.1016/j.jviromet.2023.114710] [Reference Citation Analysis]
|
| 2 |
Maghsood F, Ghorbani A, Yadegari H, Golsaz-Shirazi F, Amiri MM, Shokri F. SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design. Rev Med Virol 2023;:e2431. [PMID: 36790816 DOI: 10.1002/rmv.2431] [Reference Citation Analysis]
|
| 3 |
Kurotani KI, Hirakawa H, Shirasawa K, Tanizawa Y, Nakamura Y, Isobe S, Notaguchi M. Genome Sequence and Analysis of Nicotiana benthamiana, the Model Plant for Interactions between Organisms. Plant Cell Physiol 2023;64:248-57. [PMID: 36755428 DOI: 10.1093/pcp/pcac168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Singh DD, Han I, Choi EH, Yadav DK. A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors. Curr Issues Mol Biol 2023;45:400-33. [PMID: 36661514 DOI: 10.3390/cimb45010028] [Reference Citation Analysis]
|
| 5 |
Hare J, Riggall G, Bongers A, Ramesh K, Kokareva L, Chin B. Vaccine research and development capacity in Central and West Asia: A path toward sustainable vaccine R&D programs. Front Public Health 2023;11:1143790. [PMID: 36935694 DOI: 10.3389/fpubh.2023.1143790] [Reference Citation Analysis]
|
| 6 |
Pitino M, Fleites LA, Shrum L, Heck M, Shatters RG Jr. Plant production of high affinity nanobodies that block SARS-CoV-2 spike protein binding with its receptor, human angiotensin converting enzyme. Front Bioeng Biotechnol 2022;10:1045337. [PMID: 36619377 DOI: 10.3389/fbioe.2022.1045337] [Reference Citation Analysis]
|
| 7 |
Rozov SM, Zagorskaya AA, Konstantinov YM, Deineko EV. Three Parts of the Plant Genome: On the Way to Success in the Production of Recombinant Proteins. Plants (Basel) 2022;12. [PMID: 36616166 DOI: 10.3390/plants12010038] [Reference Citation Analysis]
|
| 8 |
Venkataraman S. Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses. Vaccines 2022;10:1805. [DOI: 10.3390/vaccines10111805] [Reference Citation Analysis]
|
| 9 |
Manan A, Pirzada RH, Haseeb M, Choi S. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach. IJMS 2022;23:10716. [DOI: 10.3390/ijms231810716] [Reference Citation Analysis]
|
| 10 |
Ghaemi A, Roshani Asl P, Zargaran H, Ahmadi D, Hashimi AA, Abdolalipour E, Bathaeian S, Miri SM. Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity. Front Immunol 2022;13:974364. [DOI: 10.3389/fimmu.2022.974364] [Reference Citation Analysis]
|
| 11 |
Balieu J, Jung J, Chan P, Lomonossoff GP, Lerouge P, Bardor M. Investigation of the N-Glycosylation of the SARS-CoV-2 S Protein Contained in VLPs Produced in Nicotiana benthamiana. Molecules 2022;27:5119. [DOI: 10.3390/molecules27165119] [Reference Citation Analysis]
|
| 12 |
Achs A, Glasa M, Šubr Z. Plum Pox Virus Genome-Based Vector Enables the Expression of Different Heterologous Polypeptides in Nicotiana benthamiana Plants. Processes 2022;10:1526. [DOI: 10.3390/pr10081526] [Reference Citation Analysis]
|
| 13 |
Ruocco V, Strasser R. Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana. Plants 2022;11:1093. [DOI: 10.3390/plants11081093] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 14 |
Mamedov T, Yuksel D, Gürbüzaslan I, Ilgın M, Gulec B, Mammadova G, Ozdarendeli A, Pavel STI, Yetiskin H, Kaplan B, Uygut MA, Hasanova G. Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants.. [DOI: 10.1101/2022.04.07.487347] [Reference Citation Analysis]
|
| 15 |
Zahmanova G, Takova K, Valkova R, Toneva V, Minkov I, Andonov A, Lukov GL. Plant-Derived Recombinant Vaccines against Zoonotic Viruses. Life 2022;12:156. [DOI: 10.3390/life12020156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Taşlı NP, Gönen ZB, Kırbaş OK, Gökdemir NS, Bozkurt BT, Bayrakcı B, Sağraç D, Taşkan E, Demir S, Ekimci Gürcan N, Bayındır Bilgiç M, Bayrak ÖF, Yetişkin H, Kaplan B, Pavel STI, Dinç G, Serhatlı M, Çakırca G, Eken A, Aslan V, Yay M, Karakukcu M, Unal E, Gül F, Basaran KE, Ozkul Y, Şahin F, Jones OY, Tekin Ş, Özdarendeli A, Cetin M. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. Front Immunol 2022;13:824378. [PMID: 35401544 DOI: 10.3389/fimmu.2022.824378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
